Medtronic plc Specialty Therapies revenue
Specialty Therapies revenue at Medtronic plc came to $774.0M for the quarter to 31 Jul 2026, up 10.3% from a year earlier.
As Medtronic plc reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 3 Sep 2026.
By quarter
| Period ending | Specialty Therapies revenue | Change on a year | Filed |
|---|---|---|---|
| 31 Jul 2026 | $774.0M | up 10.3% | 3 Sep 2026 |
| 24 Apr 2026 | $806.0M | up 6.2% | 18 Jun 2026 |
| 23 Jan 2026 | $746.0M | up 1.9% | 24 Feb 2026 |
| 24 Oct 2025 | $744.0M | up 0.9% | 25 Nov 2025 |
| 25 Jul 2025 | $702.0M | down 1.5% | 26 Aug 2025 |
| 25 Apr 2025 | $759.0M | down 2.6% | 20 Jun 2025 |
| 24 Jan 2025 | $732.0M | up 0.8% | 25 Feb 2025 |
| 25 Oct 2024 | $737.0M | up 4.5% | 26 Nov 2024 |
| 26 Jul 2024 | $713.0M | up 2.6% | 27 Aug 2024 |
| 26 Apr 2024 | $779.0M | up 2.1% | 20 Jun 2024 |
| 26 Jan 2024 | $726.0M | up 3.9% | 27 Feb 2024 |
| 27 Oct 2023 | $705.0M | up 2.8% | 30 Nov 2023 |
| 28 Jul 2023 | $695.0M | up 4.2% | 31 Aug 2023 |
| 28 Apr 2023 | $763.0M | up 11.5% | 22 Jun 2023 |
| 27 Jan 2023 | $699.0M | up 10.4% | 1 Mar 2023 |
| 28 Oct 2022 | $686.0M | up 8.2% | 1 Dec 2022 |
| 29 Jul 2022 | $667.0M | up 4.1% | 1 Sep 2022 |
| 29 Apr 2022 | $684.0M | up 4.6% | 23 Jun 2022 |
| 28 Jan 2022 | $633.0M | up 2.4% | 3 Mar 2022 |
| 29 Oct 2021 | $634.0M | up 9.1% | 2 Dec 2021 |
| 30 Jul 2021 | $641.0M | up 41.5% | 2 Sep 2021 |
| 30 Apr 2021 | $654.0M | — | 25 Jun 2021 |
| 29 Jan 2021 | $618.0M | — | 5 Mar 2021 |
| 30 Oct 2020 | $581.0M | — | 3 Dec 2020 |
| 31 Jul 2020 | $453.0M | — | 3 Sep 2020 |
Definition
Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.
Other operating KPIs of Medtronic plc: Electrophysiology Therapies revenue · Surgical & Endoscopy revenue · Cranial & Spinal Technologies revenue · Structural Heart & Aortic revenue · Coronary & Peripheral Vascular revenue · Acute Care & Monitoring revenue · Neuromodulation revenue · Reportable segment net sales · Cardiovascular revenue · Neuroscience revenue · Medical Surgical revenue · Diabetes revenue · United States revenue · International revenue · Rest of world revenue · Ireland revenue · financial statements
Every KPI and segment of MDT, in the terminal.
Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.
